Om Srivastava

Dr. Srivastava is KindredBio vice president and head of pharmaceutical development, overseeing the drug development process from inception to commercialization. He has over 20 years of experience in pharmaceutical development, CMC, biologics, and more.

Prior to KindredBio, Dr. Srivastava was the director of pharmaceutical product development at Mirati Therapeutics where he led pharmaceutical development and oncology programs. Previously, he was an associate director at Optimer Pharmaceuticals, responsible for the development of small molecules as novel antibiotics and biologics. He served as the program director for nutraceuticals and pharmaceuticals at Alberta Research Council and was awarded as the 1st Distinguished Scientist in the Province of Alberta for his contributions. Dr. Srivastava earned his Ph.D. in organic chemistry from Lucknow University and was an Alberta Heritage Foundation for Medical Research (AHFMR) fellow at the University of Alberta in Edmonton, Alberta, Canada.